Literature DB >> 26587819

Early-Life Exposure to Antibiotics, Alterations in the Intestinal Microbiome, and Risk of Metabolic Disease in Children and Adults.

Sushmita G Yallapragada, Colleen B Nash, Daniel T Robinson.   

Abstract

The intestinal microbiome is a complex ecosystem of microorganisms that colonize the human gastrointestinal tract. The microbiome evolves rapidly in early life with contributions from diet, genetics and immunomodulatory factors. Changes in composition of the microbiota due to antibiotics may lead to negative long-term effects including obesity and diabetes mellitus, as evidenced by both animal and large human studies. Inappropriate exposures to antibiotics occur frequently in early childhood. Therefore, an evidence-based system of antimicrobial use should be employed by all providers, especially those who care for pediatric patients. This article explores the natural evolution of the intestinal microbiome from the perinatal period into early childhood, the effect of antibiotics on the microbial ecology, and the implications for future health and disease. Copyright 2015, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26587819     DOI: 10.3928/00904481-20151112-09

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN: 0090-4481            Impact factor:   1.132


  19 in total

Review 1.  Population screening and treatment of Helicobacter pylori infection.

Authors:  Anthony O'Connor; Colm A O'Morain; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

Review 2.  Early life host-microbe interactions in skin.

Authors:  Laura R Dwyer; Tiffany C Scharschmidt
Journal:  Cell Host Microbe       Date:  2022-05-11       Impact factor: 31.316

3.  Alterations in the Gut Microbiome at 6 Months of Age in Obese Latino Infants.

Authors:  Annette Ville; Emma Levine; Degui Zhi; Barbara Lararia; Janet M Wojcicki
Journal:  J Am Coll Nutr       Date:  2019-09-09       Impact factor: 3.169

Review 4.  The Use of Fecal Microbiome Transplant in Treating Human Diseases: Too Early for Poop?

Authors:  Hooi-Leng Ser; Vengadesh Letchumanan; Bey-Hing Goh; Sunny Hei Wong; Learn-Han Lee
Journal:  Front Microbiol       Date:  2021-05-13       Impact factor: 5.640

5.  Early life antibiotic exposure affects pancreatic islet development and metabolic regulation.

Authors:  Jiaying Li; Kaiyuan Yang; Tingting Ju; Tracy Ho; Catharine A McKay; Yanhua Gao; Shay K Forget; Stephanie R Gartner; Catherine J Field; Catherine B Chan; Benjamin P Willing
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

6.  Antibiotic Exposure in Early Life Increases Risk of Childhood Obesity: A Systematic Review and Meta-Analysis.

Authors:  Xiaoqing Shao; Xiaolian Ding; Bin Wang; Ling Li; Xiaofei An; Qiuming Yao; Ronghua Song; Jin-An Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-20       Impact factor: 5.555

7.  Effects of oral florfenicol and azithromycin on gut microbiota and adipogenesis in mice.

Authors:  Rui Li; Hexing Wang; Qingfeng Shi; Na Wang; Zhijie Zhang; Chenglong Xiong; Jianxiang Liu; Yue Chen; Lufang Jiang; Qingwu Jiang
Journal:  PLoS One       Date:  2017-07-25       Impact factor: 3.240

Review 8.  A young infant with transient severe hypertriglyceridemia temporarily associated with meropenem administration: A case report and review of the literature.

Authors:  Susanna Esposito; Raffaella Pinzani; Genny Raffaeli; Tiziano Lucchi; Carlo Agostoni; Nicola Principi
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

Review 9.  Antibiotic Prescribing for Oro-Facial Infections in the Paediatric Outpatient: A Review.

Authors:  Najla Dar-Odeh; Hani T Fadel; Shaden Abu-Hammad; Rua'a Abdeljawad; Osama A Abu-Hammad
Journal:  Antibiotics (Basel)       Date:  2018-04-25

Review 10.  Gut microbiota in Celiac Disease: microbes, metabolites, pathways and therapeutics.

Authors:  Katherine L Olshan; Maureen M Leonard; Gloria Serena; Ali R Zomorrodi; Alessio Fasano
Journal:  Expert Rev Clin Immunol       Date:  2020-12-27       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.